Source: International Congress 2016 – New frontiers in lung transplantation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Keith Meyer (Madison, United States of America). New horizons of chronic lung allograft dysfunction. International Congress 2016 – New frontiers in lung transplantation

Member's Comments

No comment yet.

Related content which might interest you: New imaging techniques for chronic lung allograft dysfunction Source: International Congress 2016 – New frontiers in lung transplantation Year: 2016 A new biomarker for chronic lung allograft dysfunction Source: International Congress 2014 – Chronic lung allograft dysfunction: mechanisms, predictors and phenotypes Year: 2014 Evaluation of lung mechanics and the progression of disease in acute allograft rejection after lung transplantation Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation Year: 2010 Electronic nose for detecting chronic lung allograft dysfunction in lung transplant recipients Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward? Year: 2021 Prediction of chronic lung allograft dysfunction: a systems medicine challenge Source: Eur Respir J 2014; 43: 689-693 Year: 2014 New issues in lung transplantation for pulmonary hypertension Source: Virtual Congress 2020 – Lung transplantation in the era of new drugs Year: 2020 Physiology of chronic lung allograft dysfunction: back to the future? Source: Eur Respir J , 49 (4)  1700187; DOI: 10.1183/13993003.00187-2017 Year: 2017 Mechanistical differences of chronic lung allograft dysfunction phenotypes in lung transplantation Source: Annual Congress 2012 - Novel approaches to lung transplantation Year: 2012 Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD) Source: International Congress 2018 – Rare lung diseases Year: 2018 Breath VOC patterns of lung transplant recipients with and without chronic lung allograft dysfunction (CLAD) Source: International Congress 2017 – Chronic airway disease: markers of disease impact Year: 2017 Lung volumes predict survival in patients with chronic lung allograft dysfunction Source: Eur Respir J , 49 (4)  1601315; DOI: 10.1183/13993003.01315-2016 Year: 2017 A role for the mesothelium in restrictive chronic lung allograft dysfunction? Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD) Year: 2017 Pathophysiology of the lung allograft: pathways of graft rejection Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients Year: 2005 Current status of lung transplantation Source: Eur Respir J 2003; 22: 57S-64S Year: 2003 Linking clinical phenotypes of chronic lung allograft dysfunction to changes in lung structure Source: Eur Respir J 2015; 46: 1430-1439 Year: 2015 A model of chronic lung allograft rejection in the rat Source: Eur Respir J 2010; 35: 1354-1363 Year: 2010 Post-transplant bronchiolitis obliterans Source: Eur Respir J 2003 Dec 01;22(6):1007-1018 Year: 2003 New antifibrotic drugs: will interstitial diseases patients still need lung transplantation? Source: Virtual Congress 2020 – Lung transplantation in the era of new drugs Year: 2020 Risk factors for chronic lung allograft dysfunction (CLAD) in the SysCLAD cohort Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD Year: 2015